...
首页> 外文期刊>Kidney international. >Peritoneal transport assessment by peritoneal equilibration test with 3.86|[percnt]| glucose: A long-term prospective evaluation
【24h】

Peritoneal transport assessment by peritoneal equilibration test with 3.86|[percnt]| glucose: A long-term prospective evaluation

机译:通过腹膜平衡试验评估腹膜运输,结果为3.86 | [percnt] |葡萄糖:长期的前瞻性评估

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The peritoneal equilibration test (PET) with 3.86% glucose concentration (3.86%-PET) has been suggested to be more useful than the standard 2.27%-PET in peritoneal dialysis (PD), but no longitudinal data for 3.86%-PET are currently available. A total of 242 3.86%-PETs were performed in 95 incident PD patients, who underwent the first test during the first year of treatment and then once a year. The classical parameters of peritoneal transport, such as peritoneal ultrafiltration (UF), D/D0, and D/PCreat, were analyzed. In addition, the absolute dip of dialysate sodium concentration (DNa), as an expression of sodium sieving, was studied. D/D0 was stable, and a progressive decrease in UF was observed after the second PET, whereas D/PCreat firstly increased and then stabilized. DNa was the only parameter showing a progressive decrease over time. On univariate analysis, D/D0 and DNa were found to be significantly associated with the risk of developing UF failure (risk ratio (RR) 0.987 (0.973–0.999), P=0.04, and RR 0.768 (0.624–0.933), P=0.007, respectively), but on multivariate analysis only DNa showed an independent association with the risk of developing UF failure (RR 0.797 (0.649–0.965), P=0.020). UF, D/D0, and D/PCreat changed only in those patients developing UF failure, reflecting increased membrane permeability, whereas DNa significantly decreased in all patients. The 3.86%-PET allows a more complete study of peritoneal membrane transport than the standard 2.27%-PET. DNa shows a constant and significant reduction over time and is the only factor independently predicting the risk of developing UF failure in PD patients.
机译:在腹膜透析(PD)中,建议采用葡萄糖浓度为3.86%(PET)(3.86%)的腹膜平衡试验(PET)比标准的2.27%(PET)更为有用,但尚无3.86%的纵向数据-PET目前可用。在95例PD患者中共进行了242次3.86%-PETs治疗,他们在治疗的第一年进行了第一次测试,然后每年进行一次。分析了腹膜运输的经典参数,例如腹膜超滤(UF),D / D0和D / PCreat。另外,研究了透析液钠浓度(DNa)的绝对下降,作为钠筛分的一种表达。 D / D0稳定,在第二次PET后观察到UF逐渐降低,而D / PCreat先升高然后稳定。 DNa是唯一显示随时间逐渐减少的参数。在单变量分析中,发现D / D0和DNa与发生UF失败的风险显着相关(风险比(RR)0.987(0.973-0.999),P = 0.04,RR 0.768(0.624-0.933),P =分别为0.007),但在多变量分析中,只有DNa与发生UF失败的风险呈独立相关性(RR 0.797(0.649-0.965),P = 0.020)。 UF,D / D0和D / PCreat仅在发生UF失败的患者中发生改变,这反映了膜通透性增加,而所有患者中的DNa均显着降低。与标准的2.27%-PET相比,3.86%-PET能更全面地研究腹膜运输。 DNa随时间推移显示出持续且显着的降低,并且是独立预测PD患者发生UF失败风险的唯一因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号